These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6653609)

  • 1. Assessment of skeletal uptake of 99mTc-diphosphonate over a five day period.
    Fogelman I; Martin W
    Eur J Nucl Med; 1983; 8(11):489-90. PubMed ID: 6653609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal pharmacokinetics of 99mTc-diphosphonate after intravenous administration.
    Castronovo FP
    Biopharm Drug Dispos; 1981; 2(3):283-9. PubMed ID: 7295885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Caniggia A; Vattimo A
    Calcif Tissue Int; 1980; 30(1):5-13. PubMed ID: 6767533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
    Vattimo A; Martini G
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1614-7. PubMed ID: 6230088
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment.
    Waxman AD; Ducker S; McKee D; Siemsen JK; Singer FR
    Radiology; 1977 Dec; 125(3):761-4. PubMed ID: 928705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
    Fogelman I; Bessent R
    J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [99mTc-methylene diphosphonate for skeletal imaging (author's transl)].
    Yatomi K; Nakasikiryo K; Okada R; Ogasawara M; Nakagawa T; Nakagawa K; Kinoshita F
    Radioisotopes; 1977 Nov; 26(11):810-2. PubMed ID: 202999
    [No Abstract]   [Full Text] [Related]  

  • 11. [Retention of 99mTc-diphosphonate in the bones and soft tissues of rats: distribution, time factors, the effect of age].
    Kapitola J; Kobos L; Jahoda I; Vilimovská D
    Sb Lek; 1987; 89(2-3):60-6. PubMed ID: 3589471
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic uptake of technetium-99m diphosphonate in thalassemia major.
    Levy HM; Smith R
    Clin Nucl Med; 1986 Feb; 11(2):110-2. PubMed ID: 3769335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.
    Fogelman I; Bessent RG; Beastall G; Boyle IT
    Ann Intern Med; 1980 Jan; 92(1):65-7. PubMed ID: 6766051
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-body retention of 99mTc-MPD in Paget's disease.
    Vattimo A; Cantalupi D; Righi G; Martini G; Nuti R; Turchetti V
    J Nucl Med Allied Sci; 1981; 25(1-2):5-10. PubMed ID: 6454766
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [24-hour whole-body retention of 99mTc-diphosphonate. Another method for osteological examination].
    Kapitola J
    Cas Lek Cesk; 1985 Sep; 124(36):1137-9. PubMed ID: 4028103
    [No Abstract]   [Full Text] [Related]  

  • 19. Extraskeletal localization of 99mTc-labeled bone-seeking tracers in bone scintigraphy.
    Arend SM; Pauwels EK; Arndt JW; Meinders AE
    Neth J Med; 1994 Oct; 45(4):177-91. PubMed ID: 7808581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone turnover in postmenopausal osteoporosis. Determined by whole body retention and urinary excretion of 99m-technetium diphosphonate.
    Thomsen K
    Dan Med Bull; 1988 Oct; 35(5):468-79. PubMed ID: 3066591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.